Market Place
Sourcing Support
Chimerix Reports Inducement Grants Under NasdaqLR 5635(c)(4)
06 Dec 2024 //
GLOBENEWSWIRE
Chimerix Updates Phase 2 Data for Dordaviprone in H3 K27M Glioma
11 Nov 2024 //
GLOBENEWSWIRE
Chimerix Reports Q3 2024 Financial Results & Operational Update
07 Nov 2024 //
GLOBENEWSWIRE
Chimerix to Report Q3 2024 Financial Results on Nov 7
01 Nov 2024 //
GLOBENEWSWIRE
Chimerix Reports Inducement Grant Under Nasdaq Rule 5635(c)(4).
18 Oct 2024 //
GLOBENEWSWIRE
Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
03 Sep 2024 //
GLOBENEWSWIRE
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30 Aug 2024 //
GLOBENEWSWIRE
Chimerix Reports Q2 2024 Results And Operational Update
13 Aug 2024 //
GLOBENEWSWIRE
Chimerix To Report Q2 2024 Results On August 13
06 Aug 2024 //
GLOBENEWSWIRE
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2024 //
GLOBENEWSWIRE
Chimerix Fireside Chat At Jefferies Healthcare Conference
30 May 2024 //
GLOBENEWSWIRE
Chimerix Reports First Quarter 2024 Financial Results
01 May 2024 //
GLOBENEWSWIRE
Chimerix Reports Q1 2024 Results on May 1
24 Apr 2024 //
GLOBENEWSWIRE
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
16 Apr 2024 //
GLOBENEWSWIRE
Chimerix Appoints Marc D. Kozin to Board of Directors
21 Mar 2024 //
GLOBENEWSWIRE
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results
29 Feb 2024 //
GLOBENEWSWIRE
Chimerix to Present at TD Cowen 44th Annual Health Care Conference
27 Feb 2024 //
GLOBENEWSWIRE
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results
22 Feb 2024 //
GLOBENEWSWIRE
Chimerix Appoints Lisa Decker to Board of Directors
29 Dec 2023 //
GLOBENEWSWIRE
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer
04 Dec 2023 //
GLOBENEWSWIRE
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24 Nov 2023 //
GLOBENEWSWIRE
Chimerix Appointed Thomas Riga as Chief Operating and Commercial Officer
16 Nov 2023 //
GLOBENEWSWIRE
Chimerix Reports Third Quarter 2023 Financial Results
02 Nov 2023 //
GLOBENEWSWIRE
Chimerix to Report Third Quarter 2023 Financial Results
26 Oct 2023 //
GLOBENEWSWIRE
Chimerix Announces Data Highlighting Efficacy of Response to ONC201
16 Aug 2023 //
GLOBENEWSWIRE
Chimerix Reports Second Quarter 2023 Financial Results
03 Aug 2023 //
GLOBENEWSWIRE
Chimerix to Report Second Quarter 2023 Financial Results
27 Jul 2023 //
GLOBENEWSWIRE
Chimerix Announces Promotion of Michael T. Andriole to President and CEO
27 Jun 2023 //
GLOBENEWSWIRE
Chimerix to Participate in Fireside Chat at Jefferies Healthcare Conference
31 May 2023 //
GLOBENEWSWIRE
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma
25 May 2023 //
GLOBENEWSWIRE
Chimerix Reports 1Q FYR 2023 and Provides Operational Update
04 May 2023 //
GLOBENEWSWIRE
Chimerix to Report 1Q 2023 FYR and Provide an Operational Update on May 4, 2023
27 Apr 2023 //
GLOBENEWSWIRE
Chimerix Announces Presentation of Multiple Imipridone Datasets
18 Apr 2023 //
GLOBENEWSWIRE
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results
02 Mar 2023 //
GLOBENEWSWIRE
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference
28 Feb 2023 //
GLOBENEWSWIRE
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results
23 Feb 2023 //
GLOBENEWSWIRE
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference
05 Jan 2023 //
GLOBENEWSWIRE
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study
08 Dec 2022 //
GLOBENEWSWIRE
Chimerix Reports Third Quarter 2022 Financial Results
03 Nov 2022 //
GLOBENEWSWIRE
Chimerix to Report Third Quarter 2022 Financial Results
27 Oct 2022 //
GLOBENEWSWIRE
Emergent closes on buying smallpox drug Tembexa from Chimerix
28 Sep 2022 //
ENDPTS
Emergent acquires global rights for oral smallpox antiviral from Chimerix
27 Sep 2022 //
PHARMACEUTICAL-TECHNOLOGY
Emergent finalizes deal for Chimerix`s smallpox drug Tembexa
27 Sep 2022 //
FIERCEPHARMA
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions
26 Sep 2022 //
GLOBENEWSWIRE
Chimerix Appoints Christopher L. Jordan as Vice President, Regulatory Affairs
08 Aug 2022 //
GLOBENEWSWIRE
Chimerix Reports Q2 2022 Financial Results and Provides Operational Update
08 Aug 2022 //
GLOBENEWSWIRE
Chimerix to Present at Wedbush PacGrow Healthcare Conference
02 Aug 2022 //
GLOBENEWSWIRE
Chimerix to Report Second Quarter 2022 Financial Results
01 Aug 2022 //
GLOBENEWSWIRE
Chimerix (CMRX) Stock: Why It Increased Over 11% Today
25 Jul 2022 //
PULSE2
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3M
24 Jun 2022 //
GLOBENEWSWIRE
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement
23 Jun 2022 //
GLOBENEWSWIRE
Chimerix to Present at Jefferies Global Healthcare Conference
01 Jun 2022 //
GLOBENEWSWIRE
Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?
24 May 2022 //
FOOL
3 Monkeypox Stocks That Soared Last Week
23 May 2022 //
FOOL
As monkeypox quickly spreads, a handful of biotechs spring to action
20 May 2022 //
ENDPTS
Chimerix to Present at H.C. Wainwright Global Investment Conference
17 May 2022 //
GLOBENEWSWIRE
Emergent BioSolutions to Acquire from Chimerix, Exclusive WW Rights to TEMBEXA
16 May 2022 //
PRESS RELEASE
Chimerix Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Emergent adds another arrow to its medical ountermeasures quiver
16 May 2022 //
FIERCEPHARMA
Chimerix to Participate in Maxim Group Panel Discussion
12 May 2022 //
GLOBENEWSWIRE
